{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T07:43:17Z","timestamp":1775202197127,"version":"3.50.1"},"reference-count":8,"publisher":"The Endocrine Society","issue":"6","license":[{"start":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T00:00:00Z","timestamp":1645747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,17]]},"DOI":"10.1210\/clinem\/dgac109","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T18:45:43Z","timestamp":1645814743000},"page":"e2646-e2646","source":"Crossref","is-referenced-by-count":2,"title":["Letter to the Editor From Taguchi: \u201cOsteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS\u201d"],"prefix":"10.1210","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2620-1487","authenticated-orcid":false,"given":"Akira","family":"Taguchi","sequence":"first","affiliation":[{"name":"Department of Oral and Maxillofacial Radiology, School of Dentistry, Matsumoto Dental University, Hirooka, Shiojiri, Nagano, 399-0781, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2022,2,25]]},"reference":[{"key":"2022051722343469800_CIT0001","article-title":"Osteonecrosis of the jaw and antiresorptive agents in benign and malignant diseases: a critical review organized by ECTS","author":"Anastasilakis","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022051722343469800_CIT0002","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/odi.13531","article-title":"Associations between osteoporosis and risk of periodontitis: a pooled analysis of observational studies","volume":"27","author":"Xu","year":"2021","journal-title":"Oral Dis."},{"issue":"5","key":"2022051722343469800_CIT0003","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/jre.12464","article-title":"Patients with chronic periodontitis present increased risk for osteoporosis: a population-based cohort study in Taiwan","volume":"52","author":"Mau","year":"2017","journal-title":"J Periodontal Res."},{"issue":"1","key":"2022051722343469800_CIT0004","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12905-017-0440-9","article-title":"Effect of periodontitis on the development of osteoporosis: results from a nationwide population-based cohort study (2003-2013)","volume":"17","author":"Choi","year":"2017","journal-title":"BMC Womens Health."},{"issue":"1","key":"2022051722343469800_CIT0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11657-021-01054-w","article-title":"Influence of symptomatic periodontal disease on changes in skeletal bone density during medication therapy for osteoporosis in postmenopausal women: the Japanese Osteoporosis Intervention Trial (JOINT)-04 and JOINT-05","volume":"17","author":"Taguchi","year":"2021","journal-title":"Arch Osteoporos."},{"issue":"7","key":"2022051722343469800_CIT0006","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/GME.0000000000000830","article-title":"Association between osteoporosis treatment and severe periodontitis in postmenopausal women","volume":"24","author":"Passos-Soares","year":"2017","journal-title":"Menopause."},{"issue":"11","key":"2022051722343469800_CIT0007","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/GME.0000000000001393","article-title":"Improved periodontal disease and prevention of tooth loss in osteoporosis patients receiving once-yearly zoledronic acid: a randomized clinical trial","volume":"26","author":"Taguchi","year":"2019","journal-title":"Menopause."},{"issue":"1","key":"2022051722343469800_CIT0008","doi-asserted-by":"crossref","first-page":"11115","DOI":"10.1038\/s41598-020-68037-8","article-title":"Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis","volume":"10","author":"Kim","year":"2020","journal-title":"Sci Rep."}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgac109\/42829856\/dgac109.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/6\/e2646\/43739234\/dgac109.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/6\/e2646\/43739234\/dgac109.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T22:35:38Z","timestamp":1652826938000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/107\/6\/e2646\/6537122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,25]]},"references-count":8,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,2,25]]},"published-print":{"date-parts":[[2022,5,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgac109","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,6,1]]},"published":{"date-parts":[[2022,2,25]]}}}